The future of therapeutic MAbs lies in the development of economically feasible downstream processes.
Suzanne S. Farid, PhD
Advertisement
Senior Lecturer (Associate Professor) at the Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London
Articles by Suzanne S. Farid, PhD
The future of therapeutic MAbs lies in the development of economically feasible downstream processes.
Advertisement
Latest Updated Articles
Economic Drivers and Trade-Offs in Antibody Purification ProcessesPublished: March 2nd 2009 | Updated:
Economic Drivers and Trade-Offs in Antibody Purification ProcessesPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis
5
